| __timestamp | Dr. Reddy's Laboratories Limited | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 16758000 |
| Thursday, January 1, 2015 | 42585000000 | 17793000 |
| Friday, January 1, 2016 | 45702000000 | 18761000 |
| Sunday, January 1, 2017 | 46372000000 | 19287000 |
| Monday, January 1, 2018 | 46910000000 | 18707000 |
| Tuesday, January 1, 2019 | 48890000000 | 20893000 |
| Wednesday, January 1, 2020 | 50129000000 | 25678000 |
| Friday, January 1, 2021 | 54559000000 | 29665000 |
| Saturday, January 1, 2022 | 62081000000 | 43628000 |
| Sunday, January 1, 2023 | 105931000000 | 69135000 |
| Monday, January 1, 2024 | 77201000000 |
Data in motion
In the world of pharmaceuticals, Dr. Reddy's Laboratories Limited and Geron Corporation present a fascinating study in contrasts. Over the past decade, Dr. Reddy's has consistently increased its Selling, General, and Administrative (SG&A) expenses, peaking in 2023 with a staggering 105% increase from 2014. This growth reflects its aggressive expansion and market penetration strategies. In contrast, Geron Corporation's SG&A expenses have grown modestly, with a 312% increase over the same period, indicating a more conservative approach.
While Dr. Reddy's expenses surged in 2023, Geron's spending also reached its highest point, albeit at a much smaller scale. This divergence highlights the different strategic priorities of these companies. As Dr. Reddy's focuses on scaling operations, Geron appears to be investing cautiously, perhaps prioritizing research and development. The absence of data for 2024 suggests a potential shift or pause in these trends, warranting close observation.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Geron Corporation
Bristol-Myers Squibb Company or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Zoetis Inc. vs Dr. Reddy's Laboratories Limited: SG&A Expense Trends
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Geron Corporation Trends and Insights
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Merus N.V.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
BioMarin Pharmaceutical Inc. vs Geron Corporation: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for MorphoSys AG and Geron Corporation